Hedge Funds Are Buying PTC Therapeutics, Inc. (PTCT)
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies.
Ptc Therapeutics Inc. (PTCT)
Market is closed
News
- First
- << Previous
- 31 - 40
- Next >>
Amazon, Pandora, PTC Therapeutics, and More: Why These Stocks Are Trending
Although November 6 is very important to the stock market because it's election day in the United States, traders are also paying attention to several equities that are trending for various reasons.
13G Filing: Great Point Partners and PTC Therapeutics Inc. (PTCT)
Includes options exercisable on or before December 15, 2017 to purchase 260,000 shares at an exercise price of $18 per share; provided that the filing of this Schedule 13G shall not be deemed to be an...
Biotech Movers On Friday: Neurotrope Inc (NTRP) And PTC Therapeutics, Inc. (PTCT)
Here’s a look at some of the week’s biggest movers in biotech, what’s moving them, and where we expect things to go early next week and beyond.
Here's What Happened To Karyopharm Therapeutics Inc (KPTI) And PTC Therapeutics, Inc. (PTCT)
The end of the week is upon us, and it’s been a bit of a wild ride in the biotech space.
Is PTC Therapeutics, Inc. (PTCT) a Good Stock to Buy?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Why Tesla, PTC Therapeutics, Freeport-McMoRan, and Two More Are in the Spotlight
Although the broader indexes are relatively quiet, crude futures are down more than 2% in afternoon trading as some traders continue to doubt that OPEC will be able to get its act together and cut production...
Trending Stocks: PTC Therapeutics, GrubHub, Best Buy Co, and More
Among the stocks showing more volatility and making headlines are GrubHub Inc (NYSE:GRUB), Best Buy Co Inc (NYSE:BBY), PTC Therapeutics, Inc.
Here's Why These Five Stocks Are in the Spotlight Today
In this article, we will examine the reasons why PTC Therapeutics, Inc.
Ups And Downs In Biotech This Week: PTC Therapeutics, Inc. (PTCT), Puma Biotechnology Inc (PBYI) and Nektar Therapeutics (NKTR)
It’s been another busy start to the week in biotech, with a number of companies moving double digit percentage points on various fundamental releases.
- First
- << Previous
- 31 - 40
- Next >>
Billionaire Hedge Funds
